Snipe Medical

Company Overview

Snapshot

Founded in November 2021 by Ben Omri, Snipe Medical operates with 1–10 employees. The company has secured $2.09 million in total capital across 5 funding rounds from 1 investor, with Peregrine Ventures participating in multiple rounds. In February 2026, Snipe Medical received follow-on investment from.

Business overview

Snipe Medical is an early-stage startup developing a novel solution for treating lung cancer using Pulsed Electric Fields (PEF) technology. Operating within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics, the company aims to address critical needs in oncology with its innovative therapeutic approach. Currently in the R&D product stage, Snipe Medical targets the B2B market with its medical device technology.

Company Intelligence Q&A

Which investor has consistently supported Snipe Medical's funding rounds?

Peregrine Ventures has been a consistent investor in Snipe Medical, participating in multiple funding rounds, including follow-on investments in March 2025 and February 2026, and leading rounds in September 2024 and February 2023.

Has Snipe Medical received any grant funding?

In June 2025, Snipe Medical received a grant from the Israel Innovation Authority, with support from Synergy7.

When did Snipe Medical secure its seed funding round?

Snipe Medical secured a Seed funding round in September 2024, led by Peregrine Ventures.

Who are the founders of Snipe Medical?

Snipe Medical was co-founded by Ben Omri, who also serves as the CEO.